Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Uncomplicated Diverticulitis
NCT05373784Phase 1Active, not recruiting
- Start
- Mar 2024
- Primary completion
- Feb 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fecal Microbiota Transplantation Capsule in diverticulitis. Primary endpoints: Number of diverticular flares/attacks at 1 year, Number of emergency room visits and hospitalizations due to diverticulitis at 1 year and 2 more. Started Mar 2024; status: active, not recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT05373784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05373784.